Cargando…

Single dose vaccination of the ASO3-adjuvanted A(H1N1)pdm09 monovalent vaccine in health care workers elicits homologous and cross-reactive cellular and humoral responses to H1N1 strains

Healthcare workers (HCW) were prioritized for vaccination during the 2009 influenza A(H1N1)pdm09 pandemic. We conducted a clinical trial in October 2009 where 237 HCWs were immunized with a AS03-adjuvanted A(H1N1)pdm09 monovalent vaccine. In the current study, we analyzed the homologous and cross-re...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lartey, Sarah, Pathirana, Rishi D, Zhou, Fan, Jul-Larsen, Åsne, Montomoli, Emanuele, Wood, John, Cox, Rebecca Jane
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4514283/ https://www.ncbi.nlm.nih.gov/pubmed/26009966 http://dx.doi.org/10.1080/21645515.2015.1048939

Ejemplares similares

Persistently high antibody responses after AS03-adjuvanted H1N1pdm09 vaccine: Dissecting the HA specific antibody response
por: Madsen, Anders, et al.
Publicado: (2021)

The mucosal and systemic immune responses elicited by a chitosan‐adjuvanted intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2011)

A(H1N1)pdm09 influenza infection: vaccine inefficiency
por: Friedman, Nehemya, et al.
Publicado: (2017)

Antibody Responses to Influenza A/H1N1pdm09 Virus After Pandemic and Seasonal Influenza Vaccination in Healthcare Workers: A 5-Year Follow-up Study
por: Trieu, Mai-Chi, et al.
Publicado: (2019)

Augmented CD4(+) T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years
por: Trieu, Mai-Chi, et al.
Publicado: (2018)

Safety of Influenza A H1N1pdm09 Vaccines: An Overview of Systematic Reviews
por: Juvet, Lene Kristine, et al.
Publicado: (2021)

Publisher Correction: Augmented CD4(+) T-cell and humoral responses after repeated annual influenza vaccination with the same vaccine component A/H1N1pdm09 over 5 years
por: Trieu, Mai-Chi, et al.
Publicado: (2018)

Effectiveness of A(H1N1)pdm09 Influenza Vaccine in Adults Recommended for Annual Influenza Vaccination
por: Gefenaite, Giedre, et al.
Publicado: (2013)

A study of Chitosan and c‐di‐GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine
por: Svindland, Signe C., et al.
Publicado: (2012)

Repeated Influenza Vaccination Boosts and Maintains H1N1pdm09 Neuraminidase Antibody Titers
por: Hansen, Lena, et al.
Publicado: (2021)

Influenza A(H1N1)pdm09 virus and asthma
por: Obuchi, Masatsugu, et al.
Publicado: (2013)

Association between monovalent influenza A (H1N1) pdm09 vaccine and pneumonia among the elderly in the 2009–2010 season in Japan: A case-control study
por: Kondo, Kyoko, et al.
Publicado: (2015)

Development of PREDAC-H1pdm to model the antigenic evolution of influenza A/(H1N1) pdm09 viruses
por: Liu, Mi, et al.
Publicado: (2023)

Profiling of Humoral Response to Influenza A(H1N1)pdm09 Infection and Vaccination Measured by a Protein Microarray in Persons with and without History of Seasonal Vaccination
por: Huijskens, Elisabeth G. W., et al.
Publicado: (2013)

Neurological events related to influenza A (H1N1) pdm09
por: Cárdenas, Graciela, et al.
Publicado: (2014)

The 2015 influenza A (H1N1) pdm09 outbreak in India
por: Murhekar, Manoj, et al.
Publicado: (2016)

Influenza A(H1N1)pdm09 and postpandemic influenza in Lithuania
por: Ambrozaitis, Arvydas, et al.
Publicado: (2016)

Timelines of infection and transmission dynamics of H1N1pdm09 in swine
por: Canini, Laetitia, et al.
Publicado: (2020)

Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies
por: Gao, Jin, et al.
Publicado: (2019)

No Association between 2008–09 Influenza Vaccine and Influenza A(H1N1)pdm09 Virus Infection, Manitoba, Canada, 2009
por: Mahmud, Salaheddin M., et al.
Publicado: (2012)

No Evidence for Disease History as a Risk Factor for Narcolepsy after A(H1N1)pdm09 Vaccination
por: Lamb, Favelle, et al.
Publicado: (2016)

Effectiveness of MF59™ Adjuvanted Influenza A(H1N1)pdm09 Vaccine in Risk Groups in the Netherlands
por: Wijnans, Leonoor, et al.
Publicado: (2013)

Bell’s palsy and influenza(H1N1)pdm09 containing vaccines: A self-controlled case series
por: Wijnans, Leonoor, et al.
Publicado: (2017)

Differential Influence of Age on the Relationship between Genetic Mismatch and A(H1N1)pdm09 Vaccine Effectiveness
por: Cao, Lirong, et al.
Publicado: (2021)

Influenza A(H1N1)pdm09-Associated Pneumonia Deaths in Thailand
por: Bunthi, Charatdao, et al.
Publicado: (2013)

The hemagglutinin of the influenza A(H1N1)pdm09 is mutating towards stability
por: Castelán-Vega, Juan A, et al.
Publicado: (2014)

Influenza A(H1N1)pdm09 Virus in Pigs, Réunion Island
por: Cardinale, Eric, et al.
Publicado: (2012)

Fatal Influenza A(H1N1)pdm09 Encephalopathy in Immunocompetent Man
por: Simon, Marie, et al.
Publicado: (2013)

Virological characterization of influenza H1N1pdm09 in Vietnam, 2010-2013
por: Nguyen, Hang K L, et al.
Publicado: (2015)

Influenza A(H1N1)pdm09-related pneumonia and other complications
por: Viasus, Diego, et al.
Publicado: (2012)

Humoral and cellular responses to a non-adjuvanted monovalent H1N1 pandemic influenza vaccine in hospital employees
por: Herrera, Ma Teresa, et al.
Publicado: (2013)

1057 Factors Associated with Influenza A (H1N1)pdm09 (pH1N1) Vaccine Failure among Children Aged 5-17 Years
por: Mclean, Huong, et al.
Publicado: (2014)

Pandemic Influenza A(H1N1)pdm09 Seroprevalence in Sweden before and after the Pandemic and the Vaccination Campaign in 2009
por: Mörner, Andreas, et al.
Publicado: (2012)

Antibody response to influenza A(H1N1)pdm09 in vaccinated, serologically infected and unaffected pregnant women and their newborns
por: Helmig, Rikke B., et al.
Publicado: (2015)

Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease
por: Kim, Jin Hyang, et al.
Publicado: (2016)

Possible life-threatening adverse reaction to monovalent H1N1 vaccine
por: Bhurayanontachai, Rungsun
Publicado: (2010)

Use of Intravenous Peramivir for Treatment of Severe Influenza A(H1N1)pdm09
por: Louie, Janice K., et al.
Publicado: (2012)

Influenza A(H1N1)pdm09 Virus Infection in Giant Pandas, China
por: Li, Desheng, et al.
Publicado: (2014)

Cerebellitis Associated with Influenza A(H1N1)pdm09, United States, 2013
por: Sfeir, Maroun M., et al.
Publicado: (2014)

Influenza A(H1N1)pdm09 virus infection in marine mammals in California
por: Boyce, Walter M, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nrsnsa1ntgve80tlvjg9pe7005